New insights into cyclosporine A nephrotoxicity by proteome analysis

被引:71
作者
Aicher, L [1 ]
Wahl, D [1 ]
Arce, A [1 ]
Grenet, O [1 ]
Steiner, S [1 ]
机构
[1] Novartis Pharma AG, Preclin Safety, Toxicol Pathol, CH-4002 Basel, Switzerland
关键词
cyclosporine; nephrotoxicity; calbindin-D; 28; kDa; proteomics; preclinical safety;
D O I
10.1002/elps.1150191118
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Using two-dimensional gel electrophoresis (2-DE), we recently discovered an association between decreased calcium-binding protein, calbindin-D 28 kDa, urinary calcium wasting and intratubular corticomedullary calcifications in rat kidney. This observation prompted us to investigate kidney tissues of other species, including man. In this paper we show that in dogs and monkeys, which are generally devoid of cyclosporine A (CsA)-mediated nephrotoxicity, renal calbindin levels were not affected by the CsA treatment whereas in CsA-treated human kidney-transplant recipients with renal vascular or tubular toxicity, a marked decrease in renal calbindin-D 28 kDa protein level was found in most of the kidney biopsy sections. The present results strongly suggest that calbindin is a marker for CsA-nephrotoxicity. The discovery of calbindin-D 28 kDa being involved in CsA toxicity has evolved from the application of 2-DE and has not been reported previously, proving that proteomics can provide essential information in mechanistic toxicology. Considering the current improvements in proteome methods it is expected that high throughput proteomics will become an indispensable tool in preclinical safety testing.
引用
收藏
页码:1998 / 2003
页数:6
相关论文
共 10 条
  • [1] Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization
    Aicher, L
    Meier, G
    Norcross, AJ
    Jakubowski, J
    Varela, MD
    Cordier, A
    Steiner, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (05) : 723 - 731
  • [2] A comparison of selected mRNA and protein abundances in human liver
    Anderson, L
    Seilhamer, J
    [J]. ELECTROPHORESIS, 1997, 18 (3-4) : 533 - 537
  • [3] FEHER JJ, 1983, AM J PHYSIOL, V244, P303
  • [4] The cyclosporine A-induced decrease in rat renal calbindin-D28kDa protein as a consequence of a decrease in its mRNA
    Grenet, O
    Varela, MD
    Staedtler, F
    Steiner, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 55 (07) : 1131 - 1133
  • [5] PHYSIOLOGY AND BIOCHEMISTRY OF VITAMIN D-DEPENDENT CALCIUM-BINDING PROTEINS
    GROSS, M
    KUMAR, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02): : F195 - F209
  • [6] KAHAN BD, 1993, TRANSPLANT P, V25, P508
  • [7] MILLER BE, 1983, METHOD ENZYMOL, V102, P291
  • [8] NEMERE I, 1990, MINER ELECTROL METAB, V16, P109
  • [9] PROTEIN VARIABILITY IN MALE AND FEMALE WISTAR RAT-LIVER PROTEINS
    STEINER, S
    WAHL, D
    VARELA, MDC
    AICHER, L
    PRIETO, P
    [J]. ELECTROPHORESIS, 1995, 16 (10) : 1969 - 1976
  • [10] Cyclosporine a decreases the protein level of the calcium-binding protein calbindin-D 28kDa in rat kidney
    Steiner, S
    Aicher, L
    Raymackers, J
    Meheus, L
    EsquerBlasco, R
    Anderson, NL
    Cordier, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 51 (03) : 253 - 258